Education
About Us
Working with TipRanks
Follow Us
Star Combo Pharma Ltd. (AU:S66)
ASX:S66
RESEARCH TOOLSreports
Total Valuation
Star Combo Pharma Ltd. has a market cap or net worth of AU$20.25M. The enterprise value is AU$20.43M.
Market CapAU$20.25M
Enterprise ValueAU$20.43M
Share Statistics
Star Combo Pharma Ltd. has 135,002,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding135,002,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Star Combo Pharma Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.42%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)1.42%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.61
Inventory Turnover2.93
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio22.7
PS Ratio0.00
PB Ratio0.62
Price to Fair Value0.45
Price to FCF6.09
Price to Operating Cash Flow4.39
PEG Ratio―
Income Statement
In the last 12 months, Star Combo Pharma Ltd. had revenue of 26.02M and earned 747.33K in profits. Earnings per share was 0.01.
Revenue26.02M
Gross Profit7.41M
Operating Income723.43K
Pretax Income1.00M
Net Income747.33K
EBITDA2.79M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 5.13M and capital expenditures -1.07M, giving a free cash flow of 4.15M billion.
Operating Cash Flow5.13M
Free Cash Flow4.15M
Free Cash Flow per Share0.03
Dividends & Yields
Star Combo Pharma Ltd. pays an annual dividend of AU$0.004, resulting in a dividend yield of 2.47%
Dividend Per ShareAU$0.004
Dividend Yield2.47%
Payout Ratio42.86%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.11
52-Week Price Change36.36%
50-Day Moving Average0.15
200-Day Moving Average0.14
Relative Strength Index (RSI)50.03
Average Volume (3m)6.78K
Important Dates
Star Combo Pharma Ltd. upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateOct 14, 2024
Financial Position
Star Combo Pharma Ltd. as a current ratio of 3.77, with Debt / Equity ratio of 11.71%
Current Ratio3.77
Quick Ratio2.47
Debt to Market Cap<0.01
Net Debt to EBITDA0.67
Interest Coverage Ratio3.69
Taxes
In the past 12 months, Star Combo Pharma Ltd. has paid 253.73K in taxes.
Income Tax253.73K
Effective Tax Rate0.25
Enterprise Valuation
Star Combo Pharma Ltd. EV to EBITDA ratio is 6.00, with an EV/FCF ratio of -9.51.
EV to Sales0.64
EV to EBITDA6.00
EV to Free Cash Flow-9.51
EV to Operating Cash Flow-52.85
Balance Sheet
Star Combo Pharma Ltd. has AU$12.95M in cash and marketable securities with AU$3.94M in debt, giving a net cash position of -AU$9.02M billion.
Cash & Marketable SecuritiesAU$12.95M
Total DebtAU$3.94M
Net Cash-AU$9.02M
Net Cash Per Share-AU$0.07
Tangible Book Value Per ShareAU$0.24
Margins
Gross margin is 21.15%, with operating margin of 2.78%, and net profit margin of 2.87%.
Gross Margin21.15%
Operating Margin2.78%
Pretax Margin3.85%
Net Profit Margin2.87%
EBITDA Margin10.71%
EBIT Margin4.60%
Analyst Forecast
The average price target for Star Combo Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast16.45%
EPS Growth Forecast83.33%